Newron Pharmaceuticals Statistics
Total Valuation
SWX:NWRN has a market cap or net worth of CHF 130.53 million. The enterprise value is 165.07 million.
Market Cap | 130.53M |
Enterprise Value | 165.07M |
Important Dates
The last earnings date was Tuesday, April 1, 2025.
Earnings Date | Apr 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SWX:NWRN has 19.96 million shares outstanding. The number of shares has increased by 4.45% in one year.
Current Share Class | n/a |
Shares Outstanding | 19.96M |
Shares Change (YoY) | +4.45% |
Shares Change (QoQ) | +4.02% |
Owned by Insiders (%) | 5.40% |
Owned by Institutions (%) | 6.05% |
Float | 18.88M |
Valuation Ratios
The trailing PE ratio is 8.20.
PE Ratio | 8.20 |
Forward PE | n/a |
PS Ratio | 2.53 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 11.11 |
EV / Sales | 3.42 |
EV / EBITDA | 12.77 |
EV / EBIT | 12.90 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 2.85 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 2.19M |
Profits Per Employee | 675,612 |
Employee Count | 22 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.18% in the last 52 weeks. The beta is 0.63, so SWX:NWRN's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | -17.18% |
50-Day Moving Average | 9.12 |
200-Day Moving Average | 8.38 |
Relative Strength Index (RSI) | 20.71 |
Average Volume (20 Days) | 74,400 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:NWRN had revenue of CHF 48.21 million and earned 14.86 million in profits. Earnings per share was 0.80.
Revenue | 48.21M |
Gross Profit | 48.21M |
Operating Income | 12.80M |
Pretax Income | 14.86M |
Net Income | 14.86M |
EBITDA | 12.93M |
EBIT | 12.80M |
Earnings Per Share (EPS) | 0.80 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 26.55% and 30.83%.
Gross Margin | 100.00% |
Operating Margin | 26.55% |
Pretax Margin | 30.83% |
Profit Margin | 30.83% |
EBITDA Margin | 26.81% |
EBIT Margin | 26.55% |
FCF Margin | n/a |
Dividends & Yields
SWX:NWRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.45% |
Shareholder Yield | -4.45% |
Earnings Yield | 11.39% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |